Can hyperthermic intrathoracic perfusion chemotherapy added to lung sparing surgery be the solution for malignant pleural mesothelioma?

Isik, Ahmet; Sanli, Maruf; Dikensoy, ÖNER; Aytekin, Ilknur; Benli, Yunus; Sevinc, Alper; Camci, Celaletdin; Tuncozgur, Bulent; Elbeyli, Levent

doi:10.5606/tgkdc.dergisi.2016.11798

Can hyperthermic intrathoracic perfusion chemotherapy added to lung sparing surgery be the solution for malignant pleural mesothelioma?

Isik A. F., Sanli M., Dikensoy Ö., Aytekin I., Benli Y., Sevinc A., ...Daha Fazla

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.24, sa.2, ss.325-332, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 2
Basım Tarihi: 2016
Doi Numarası: 10.5606/tgkdc.dergisi.2016.11798
Dergi Adı: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.325-332
Anahtar Kelimeler: Hyperthermic perfusion chemotherapy, mesothelioma, pleura, surgery, EXTRAPLEURAL PNEUMONECTOMY, INTERNATIONAL MESOTHELIOMA, PERITONEAL CARCINOMATOSIS, COMPLETE RESECTION, EXPERIENCE, MANAGEMENT, SURVIVAL, CANCER
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: This study aims to investigate whether hyperthermic intrathoracic perfusion chemotherapy added to lung sparing cytoreductive surgery is superior to extrapleural pneumonectomy in patients with malignant pleural mesothelioma in terms of survival.